Beryl Drugs Limited (BERLDRG.BO)
INR 19.55
(-3.65%)
INR 19.55
(-3.65%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 26.63 Million INR | 20.15% |
| 2022 | 22.34 Million INR | 300.11% |
| 2021 | 5.57 Million INR | -65.55% |
| 2020 | 20.67 Million INR | 44.91% |
| 2019 | 11.12 Million INR | -11.73% |
| 2018 | 12.39 Million INR | -2.49% |
| 2017 | 17.35 Million INR | 655.81% |
| 2016 | 2.36 Million INR | -80.43% |
| 2015 | 8.49 Million INR | -1.33% |
| 2014 | 8.53 Million INR | -4.57% |
| 2013 | 9.27 Million INR | -5.78% |
| 2012 | 9.86 Million INR | 108.52% |
| 2011 | 4.73 Million INR | -8.27% |
| 2010 | 5.15 Million INR | -7.59% |
| 2009 | 5.58 Million INR | 18.39% |
| 2008 | 4.71 Million INR | -16.61% |
| 2007 | 5.65 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 9.46 Million INR | 3674.33% |
| 2023 Q2 | 7.18 Million INR | -36.62% |
| 2023 Q3 | 7.97 Million INR | 11.0% |
| 2023 Q1 | 11.32 Million INR | 296.08% |
| 2023 FY | - INR | 20.15% |
| 2023 Q4 | 261 Thousand INR | -96.73% |
| 2022 Q4 | 2.86 Million INR | -60.01% |
| 2022 FY | - INR | 300.11% |
| 2022 Q1 | 5.94 Million INR | 294.98% |
| 2022 Q2 | 6.29 Million INR | 5.99% |
| 2022 Q3 | 7.15 Million INR | 13.54% |
| 2021 Q3 | 2.45 Million INR | 363.16% |
| 2021 Q4 | -3.04 Million INR | -224.41% |
| 2021 FY | - INR | -65.55% |
| 2021 Q1 | 7.08 Million INR | 221.78% |
| 2021 Q2 | -931 Thousand INR | -113.13% |
| 2020 Q1 | 3.09 Million INR | 223.07% |
| 2020 FY | - INR | 44.91% |
| 2020 Q3 | 1.69 Million INR | -81.48% |
| 2020 Q4 | 2.2 Million INR | 29.96% |
| 2020 Q2 | 9.15 Million INR | 195.26% |
| 2019 Q2 | 3.58 Million INR | -38.98% |
| 2019 FY | - INR | -11.73% |
| 2019 Q1 | 5.88 Million INR | 252.69% |
| 2019 Q3 | 4.57 Million INR | 27.58% |
| 2019 Q4 | -2.51 Million INR | -154.99% |
| 2018 Q4 | 1.66 Million INR | -52.02% |
| 2018 Q3 | 3.47 Million INR | -2.44% |
| 2018 FY | - INR | -2.49% |
| 2018 Q1 | 3.91 Million INR | -59.83% |
| 2018 Q2 | 3.56 Million INR | -9.01% |
| 2017 Q1 | 2.66 Million INR | 113.83% |
| 2017 Q4 | 9.74 Million INR | 284.38% |
| 2017 Q3 | 2.53 Million INR | 2.46% |
| 2017 FY | - INR | 655.81% |
| 2017 Q2 | 2.47 Million INR | -6.95% |
| 2016 Q1 | 2.95 Million INR | 923.88% |
| 2016 FY | - INR | -80.43% |
| 2016 Q4 | 1.24 Million INR | 89.63% |
| 2016 Q3 | 656 Thousand INR | -76.17% |
| 2016 Q2 | 2.75 Million INR | -6.96% |
| 2015 Q3 | 2.05 Million INR | -45.36% |
| 2015 Q4 | 289 Thousand INR | -85.93% |
| 2015 Q2 | 3.75 Million INR | 40.31% |
| 2015 FY | - INR | -1.33% |
| 2015 Q1 | 2.67 Million INR | 202.95% |
| 2014 Q4 | 884.31 Thousand INR | -63.64% |
| 2014 FY | - INR | -4.57% |
| 2014 Q1 | 2.29 Million INR | 276.91% |
| 2014 Q2 | 3.25 Million INR | 41.54% |
| 2014 Q3 | 2.43 Million INR | -25.26% |
| 2013 Q2 | 2.82 Million INR | -6.46% |
| 2013 FY | - INR | -5.78% |
| 2013 Q1 | 3.01 Million INR | 327.32% |
| 2013 Q3 | 3.06 Million INR | 8.61% |
| 2013 Q4 | -1.29 Million INR | -142.4% |
| 2012 Q1 | 3.73 Million INR | 135.03% |
| 2012 Q4 | -1.32 Million INR | -133.38% |
| 2012 FY | - INR | 108.52% |
| 2012 Q3 | 3.97 Million INR | 14.45% |
| 2012 Q2 | 3.47 Million INR | -6.89% |
| 2011 FY | - INR | -8.27% |
| 2011 Q4 | -10.64 Million INR | -479.93% |
| 2011 Q3 | 2.8 Million INR | 0.0% |
| 2010 FY | - INR | -7.59% |
| 2009 FY | - INR | 18.39% |
| 2008 Q4 | 721 Thousand INR | 0.0% |
| 2008 FY | - INR | -16.61% |
| 2007 FY | - INR | 0.0% |
| 2007 Q4 | -360 Thousand INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -4070.463% |
| Sastasundar Ventures Limited | -203.51 Million INR | 113.09% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -129.964% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 70.072% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 68.372% |
| Sunil Healthcare Limited | 93.07 Million INR | 71.38% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -61.273% |
| MedPlus Health Services Limited | 3.94 Billion INR | 99.324% |
| Zenith Healthcare Limited | 4.98 Million INR | -434.062% |
| Patidar Buildcon Limited | -5.52 Million INR | 582.067% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 69.584% |
| Roopa Industries Limited | 55.7 Million INR | 52.175% |
| Smruthi Organics Limited | 120.31 Million INR | 77.858% |
| Trident Lifeline Limited | 102.69 Million INR | 74.06% |
| Bacil Pharma Limited | -569.32 Thousand INR | 4779.091% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 121.608% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -67.784% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 117.636% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 2.037% |
| PANJON LTD. | 4.08 Million INR | -551.48% |
| Tyche Industries Limited | 128.2 Million INR | 79.222% |
| Trimurthi Limited | -2.47 Million INR | 1174.799% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 239.823% |
| Anuh Pharma Limited | 878.5 Million INR | 96.968% |
| Crestchem Limited | 30.33 Million INR | 12.182% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 346.247% |
| Zenlabs Ethica Limited | 27.09 Million INR | 1.687% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 93.115% |
| ANG Lifesciences India Limited | 90.66 Million INR | 70.617% |
| Parmax Pharma Limited | 22.93 Million INR | -16.137% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 93.152% |
| Deccan Health Care Limited | 37.5 Million INR | 28.974% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 87.701% |
| Norris Medicines Limited | -1.78 Million INR | 1593.096% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 89.519% |
| Veerhealth Care Limited | 15.99 Million INR | -66.546% |
| Makers Laboratories Limited | 25.81 Million INR | -3.204% |
| Lactose (India) Limited | 201.22 Million INR | 86.761% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 127.7% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 84.383% |
| Mercury Laboratories Limited | 101.18 Million INR | 73.674% |
| Gennex Laboratories Limited | 219.35 Million INR | 87.856% |
| PRAVEG LIMITED | 321.43 Million INR | 91.712% |
| Denis Chem Lab Limited | 224.84 Million INR | 88.152% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 95.636% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 92.95% |
| Colinz Laboratories Limited | 5.42 Million INR | -390.77% |
| Godavari Drugs Limited | 134.62 Million INR | 80.212% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 6661.33% |
| Zenotech Laboratories Limited | 172.64 Million INR | 84.57% |
| Panchsheel Organics Limited | 189.36 Million INR | 85.933% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 94.064% |
| Vivanza Biosciences Limited | 11.2 Million INR | -137.763% |
| Phaarmasia Limited | -1.58 Million INR | 1783.881% |
| Bharat Parenterals Limited | 265.74 Million INR | 89.976% |
| Medi-Caps Limited | 4.77 Million INR | -458.353% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 1079.375% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 96.794% |
| BDH Industries Limited | 124.27 Million INR | 78.564% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 182.272% |
| Coral Laboratories Limited | 227.07 Million INR | 88.269% |
| Concord Drugs Limited | 40.52 Million INR | 34.257% |
| Evoq Remedies Limited | 6.18 Million INR | -330.496% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 67.755% |
| Transchem Limited | 56.61 Million INR | 52.944% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -124.083% |
| Parnax Lab Limited | 243.59 Million INR | 89.064% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 40.543% |
| Kerala Ayurveda Limited | 70.78 Million INR | 62.367% |
| Cian Healthcare Limited | 122.56 Million INR | 78.266% |
| Trinity League India Limited | -26.25 Million INR | 201.47% |
| Syschem (India) Limited | 70.4 Million INR | 62.161% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 410.731% |
| Natural Capsules Limited | 219.9 Million INR | 87.886% |
| Auro Laboratories Limited | 121.73 Million INR | 78.117% |